The global biologics safety testing market was valued at USD 3,589.5 million in 2022, which is expected to reach USD 9,370.3 million by 2030, growing at a CAGR of 12.7% during 2022–2030.To learn more about this report: https://bit.ly/3pzynnmIn healthcare, biologics like cell...
